— Know what they know.
Not Investment Advice

CTKB NASDAQ

Cytek Biosciences, Inc.
1W: +3.9% 1M: +25.2% 3M: +27.1% YTD: +19.3% 1Y: +62.6% 3Y: -5.0% 5Y: -75.7%
$5.87
+0.06 (+1.03%)
 
Weekly Expected Move ±6.4%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 67 · $758.1M mcap · 118M float · 1.09% daily turnover · Short 32% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -40.8%  ·  5Y Avg: -12.3%
Cost Advantage ★
44
Intangibles
38
Switching Cost
39
Network Effect
38
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CTKB has No discernible competitive edge (39.0/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -40.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$5
Low
$5
Avg Target
$5
High
Based on 1 analyst since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$5.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-07 Morgan Stanley — $6 $5 -0 +20.3% $4.16
2026-05-13 Stephens — Initiated $5 — +17.6% $4.04
2026-05-12 Morgan Stanley — $6 $6 -0 +35.3% $4.07
2025-12-01 Morgan Stanley — Initiated $6 — +12.6% $5.33
2025-03-04 Piper Sandler — $8 $8 -0 +85.6% $4.31
2025-02-02 Goldman Sachs Matthew Sykes Initiated $5 — +1.9% $5.15
2024-05-13 Piper Sandler Dave Westenberg $16 $8 -8 +38.2% $6.15
2022-08-17 Piper Sandler David Westenberg $12 $16 +4 +13.6% $14.08
2022-05-15 Piper Sandler David Westenberg Initiated $12 — +27.9% $9.38

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CTKB receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ C
2026-05-14 C C+
2026-05-11 C+ C
2026-05-08 C C+
2026-04-01 C+ C
2026-01-13 B- C+
2026-01-03 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 33 Grade D
Profitability
18
Balance Sheet
39
Earnings Quality
26
Growth
37
Value
39
Momentum
38
Safety
80
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CTKB scores highest in Safety (80/100) and lowest in Profitability (18/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.30
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓ ✓
Beneish M-Score
-3.64
Unlikely Manipulator
Ohlson O-Score
-7.42
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 57.6/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.07x
Accruals: -15.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CTKB scores 3.30, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CTKB scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CTKB's score of -3.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CTKB's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CTKB receives an estimated rating of BBB (score: 57.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-9.42x
PEG
0.07x
P/S
3.67x
P/B
2.36x
P/FCF
-47.48x
P/OCF
—
EV/EBITDA
-12.45x
EV/Revenue
1.63x
EV/EBIT
-8.65x
EV/FCF
-27.98x
Earnings Yield
-14.05%
FCF Yield
-2.11%
Shareholder Yield
0.01%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CTKB currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.974
NI / EBT
×
Interest Burden
1.045
EBT / EBIT
×
EBIT Margin
-0.189
EBIT / Rev
×
Asset Turnover
0.440
Rev / Assets
×
Equity Multiplier
1.344
Assets / Equity
=
ROE
-23.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CTKB's ROE of -23.0% is driven by Asset Turnover (0.440), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.97 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1305 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.87
Median 1Y
$3.81
5th Pctile
$1.43
95th Pctile
$10.28
Ann. Volatility
64.5%
Analyst Target
$5.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Wenbin Jiang, Ph.D.
Chief Executive Officer and President
$620,000 $2,000,000 $5,120,061
William McCombe Financial
ancial Officer
$450,000 $900,000 $2,460,979
Valerie Barnett Legal
Legal Officer and Corporate Secretary
$475,000 $750,000 $2,174,943
Ming Yan, Ph.D.
Chief Technology Officer
$425,000 $425,000 $1,457,420
Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
$375,000 $250,000 $1,021,730

CEO Pay Ratio

33:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,120,061
Avg Employee Cost (SGA/emp): $154,382
Employees: 702

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
702
+8.3% YoY
Revenue / Employee
$287,027
Rev: $201,493,000
Profit / Employee
$-94,785
NI: $-66,539,000
SGA / Employee
$154,382
Avg labor cost proxy
R&D / Employee
$51,949
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 0.4% 0.1% -0.4% -0.6% -0.5% 0.6% -0.5% -1.4% -3.4% -3.0% -2.8% -4.3% -2.5% -1.5% -2.9% -1.7% -3.4% -18.0% -20.9% -23.0% -23.04%
ROA 0.3% 0.0% -0.4% -0.5% -0.4% 0.5% -0.4% -1.2% -2.8% -2.4% -2.3% -3.5% -2.0% -1.2% -2.3% -1.3% -2.6% -13.8% -15.9% -17.1% -17.14%
ROIC 7.6% 1.1% 2.5% 1.0% -0.5% -3.5% -6.5% -11.1% -15.3% -15.2% -15.2% -16.2% -16.0% -12.0% -15.1% -15.2% -16.5% -28.2% -34.1% -40.8% -40.82%
ROCE 0.6% 0.8% 0.2% -0.0% -0.0% 0.8% -0.4% -1.5% -2.9% -3.1% -3.2% -3.4% -2.5% -4.8% -5.5% -5.3% -7.1% -7.3% -9.2% -10.8% -10.77%
Gross Margin 61.9% 60.8% 57.5% 61.2% 66.4% 60.8% 56.7% 56.7% 56.6% 56.8% 51.3% 54.6% 56.3% 58.5% 48.6% 52.3% 52.7% 52.9% 48.2% 58.9% 58.87%
Operating Margin 8.4% 3.4% -6.7% -2.2% 3.4% 0.2% -32.8% -18.4% -13.4% -0.2% -23.9% -18.3% -8.2% 5.2% -36.1% -23.3% -17.6% -9.0% -41.8% -23.7% -23.68%
Net Margin 4.1% -3.1% -5.8% -1.5% 4.1% 7.3% -18.4% -8.8% -13.5% 9.4% -13.8% -22.4% 1.8% 16.8% -27.5% -12.2% -10.5% -70.9% -42.7% -25.3% -25.26%
EBITDA Margin 7.9% 4.2% -3.5% 0.3% 8.1% 13.8% -19.9% -9.2% -2.1% 11.9% -13.6% -9.8% 6.0% -4.3% -19.5% -7.4% -8.1% -0.4% -32.4% -17.4% -17.40%
FCF Margin -0.4% 5.5% 1.6% -6.1% -11.3% -13.4% -10.5% -6.2% -4.3% 0.2% 0.7% 5.4% 14.3% 10.9% 8.9% 5.6% -3.0% -4.4% -6.2% -5.8% -5.84%
OCF Margin 3.4% 9.0% 4.7% -2.9% -8.4% -7.5% -4.8% -0.7% 1.1% 2.7% 3.2% 7.8% 16.3% 12.7% 10.8% 7.8% -1.0% -2.3% -3.6% -2.9% -2.92%
ROE 3Y Avg snapshot only -10.41%
ROE 5Y Avg snapshot only -6.65%
ROA 3Y Avg snapshot only -7.65%
ROIC 3Y Avg snapshot only -17.83%
ROIC Economic snapshot only -10.25%
Cash ROA snapshot only -1.35%
Cash ROIC snapshot only -6.99%
CROIC snapshot only -13.98%
NOPAT Margin snapshot only -17.06%
Pretax Margin snapshot only -19.75%
R&D / Revenue snapshot only 18.03%
SGA / Revenue snapshot only 56.80%
SBC / Revenue snapshot only 10.34%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 1713.36 8098.52 -805.51 -603.41 -952.33 543.10 -563.41 -193.46 -53.23 -98.13 -76.32 -41.78 -72.41 -139.32 -45.74 -67.42 -34.52 -9.73 -7.60 -7.12 -9.424
P/S Ratio 70.78 25.31 13.32 9.71 13.21 8.53 7.50 6.61 4.10 6.18 4.38 3.71 3.66 4.18 2.61 2.20 2.25 3.21 2.75 2.77 3.667
P/B Ratio 6.04 4.58 3.54 3.51 4.90 3.29 2.94 2.74 1.81 3.03 2.24 1.88 1.91 2.12 1.36 1.14 1.17 1.89 1.72 1.78 2.360
P/FCF -16550.86 463.06 827.20 -159.83 -116.74 -63.42 -71.37 -106.53 -94.98 2625.81 611.75 68.82 25.63 38.39 29.35 39.01 -74.96 -73.80 -44.29 -47.48 -47.484
P/OCF 2095.59 280.61 281.43 — — — — — 383.12 225.74 137.69 47.52 22.36 33.04 24.16 28.39 — — — — —
EV/EBITDA 760.15 344.42 355.45 346.51 456.39 122.21 359.35 -439.72 -76.05 -156.45 -130.86 -98.64 -719.33 -57.59 -22.02 -17.84 -11.91 -26.27 -15.19 -12.45 -12.447
EV/Revenue 59.82 20.33 10.12 7.46 11.10 6.56 5.80 5.00 2.62 4.89 3.10 2.38 2.32 2.88 1.34 0.99 1.10 2.08 1.65 1.63 1.635
EV/EBIT 817.25 431.62 1482.90 -73806.39 -53625.54 280.71 -529.06 -121.07 -35.90 -69.21 -45.05 -32.00 -43.13 -28.15 -11.55 -8.68 -7.25 -15.00 -9.88 -8.65 -8.654
EV/FCF -13987.79 372.02 628.00 -122.70 -98.11 -48.78 -55.22 -80.59 -60.52 2078.96 433.69 44.10 16.27 26.45 15.11 17.47 -36.59 -47.75 -26.50 -27.98 -27.982
Earnings Yield 0.1% 0.0% -0.1% -0.2% -0.1% 0.2% -0.2% -0.5% -1.9% -1.0% -1.3% -2.4% -1.4% -0.7% -2.2% -1.5% -2.9% -10.3% -13.2% -14.0% -14.05%
FCF Yield -0.0% 0.2% 0.1% -0.6% -0.9% -1.6% -1.4% -0.9% -1.1% 0.0% 0.2% 1.5% 3.9% 2.6% 3.4% 2.6% -1.3% -1.4% -2.3% -2.1% -2.11%
PEG Ratio snapshot only 0.072
Price/Tangible Book snapshot only 1.975
EV/Gross Profit snapshot only 3.072
Shareholder Yield snapshot only 0.01%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 14.65 13.01 10.26 10.47 10.70 9.26 7.53 7.93 7.20 6.97 6.99 7.33 6.21 5.86 5.62 5.22 5.17 5.04 4.69 4.48 4.481
Quick Ratio 13.74 12.04 9.37 9.40 9.51 8.28 6.30 6.70 6.06 5.89 6.01 6.38 5.47 5.21 4.95 4.55 4.48 4.42 4.07 3.86 3.862
Debt/Equity 0.00 0.00 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.02 0.04 0.04 0.06 0.09 0.10 0.11 0.08 0.082
Net Debt/Equity -0.94 -0.90 -0.85 -0.82 -0.78 -0.76 -0.67 -0.67 -0.66 -0.63 -0.65 -0.68 -0.70 -0.66 -0.66 -0.63 -0.60 -0.67 -0.69 -0.73 -0.732
Debt/Assets 0.00 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.03 0.03 0.05 0.07 0.07 0.08 0.06 0.059
Debt/EBITDA 0.00 0.00 4.83 4.65 4.19 2.06 6.44 -8.12 -2.43 -2.34 -3.02 -2.89 -13.86 -1.70 -1.32 -2.19 -1.94 -2.07 -1.64 -0.97 -0.974
Net Debt/EBITDA -139.29 -84.29 -112.75 -104.87 -86.64 -36.69 -105.09 141.53 43.30 41.15 53.73 55.29 414.15 26.00 20.76 22.00 12.50 14.33 10.20 8.67 8.675
Interest Coverage 5.71 3.70 0.49 -0.01 -0.01 1.49 -0.69 -3.00 -5.64 -6.59 -7.52 -9.39 -9.95 -29.57 -42.18 -27.01 -24.86 -14.51 -17.97 -22.16 -22.165
Equity Multiplier 1.13 1.14 1.19 1.20 1.20 1.22 1.24 1.24 1.25 1.26 1.25 1.24 1.27 1.26 1.27 1.31 1.31 1.35 1.37 1.39 1.388
Cash Ratio snapshot only 3.107
Debt Service Coverage snapshot only -15.410
Cash to Debt snapshot only 9.902
FCF to Debt snapshot only -0.456
Defensive Interval snapshot only 739.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.08 0.16 0.22 0.30 0.32 0.33 0.33 0.35 0.36 0.38 0.39 0.39 0.40 0.40 0.40 0.40 0.40 0.42 0.44 0.44 0.440
Inventory Turnover 0.48 0.88 1.14 1.30 1.54 1.57 1.20 1.26 1.33 1.53 1.44 1.54 1.60 1.71 1.77 1.80 1.86 2.10 2.07 1.90 1.901
Receivables Turnover 1.17 2.46 3.56 4.03 4.48 4.17 4.52 4.06 3.85 3.68 4.30 4.19 3.72 3.44 3.74 3.89 3.60 3.27 3.82 3.90 3.903
Payables Turnover 3.34 9.35 7.24 8.72 12.41 16.09 11.42 14.27 14.95 21.33 19.85 28.39 17.96 20.87 17.81 17.79 14.07 16.25 15.19 12.67 12.670
DSO 313 148 102 90 82 87 81 90 95 99 85 87 98 106 98 94 101 111 96 94 93.5 days
DIO 767 414 321 281 236 232 305 289 274 238 254 237 229 214 206 203 196 174 176 192 192.0 days
DPO 109 39 50 42 29 23 32 26 24 17 18 13 20 17 20 21 26 22 24 29 28.8 days
Cash Conversion Cycle 970 523 373 330 289 297 354 353 345 320 320 312 306 303 283 277 272 263 248 257 256.8 days
Fixed Asset Turnover snapshot only 6.508
Operating Cycle snapshot only 285.6 days
Cash Velocity snapshot only 0.789
Capital Intensity snapshot only 2.162
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 3.5% 1.2% 53.3% 18.3% 18.5% 17.7% 20.9% 12.6% 9.9% 3.9% -1.9% -0.8% -2.2% 0.5% 3.6% 5.4% 5.44%
Net Income — — — — -2.5% 10.2% -23.3% -1.5% -5.6% -5.7% -4.2% -1.9% 28.1% 50.5% 2.2% 63.5% -26.2% -10.1% -5.6% -11.6% -11.59%
EPS — — — — -2.2% 8.3% -21.9% -1.5% -5.7% -5.9% -4.4% -2.0% 26.2% 49.9% 0.3% 62.2% -31.4% -10.1% -5.6% -11.3% -11.34%
FCF — — — — -118.0% -6.5% -11.0% -20.8% 54.8% 1.0% 1.1% 2.0% 4.6% 47.1% 11.2% 3.8% -1.2% -1.4% -1.7% -2.1% -2.09%
EBITDA — — — — 39.0% 1.0% -13.0% -1.6% -2.7% -1.7% -2.8% -1.4% 89.7% -66.3% -1.5% -1.3% -26.9% -58.9% -84.1% -1.5% -1.51%
Op. Income — — — — -1.2% -1.4% -7.3% -21.5% -47.4% -14.4% -1.3% -30.1% 14.4% 26.3% 6.3% -4.0% -34.5% -96.8% -77.2% -66.2% -66.22%
OCF Growth snapshot only -1.40%
Asset Growth snapshot only -9.40%
Equity Growth snapshot only -14.73%
Debt Growth snapshot only 11.74%
Shares Change snapshot only 1.99%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — 80.2% 39.9% 22.1% 9.7% 8.4% 7.1% 7.1% 5.6% 5.59%
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — 73.2% 35.2% 18.5% 6.0% 3.4% 1.1% 1.2% 1.4% 1.43%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — 76.0% 1.2% — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — 2.0% 56.6% 60.7% — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 2.6% 2.5% -0.2% 0.0% -0.3% -3.9% -5.0% -5.2% -5.23%
Assets 5Y — — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -1.5% -0.8% -2.3% -2.8% -3.1% -7.0% -8.2% -8.8% -8.78%
Book Value 3Y — — — — — — — — — — — — -6.4% -4.9% -0.9% -0.9% -0.4% -4.9% -6.6% -7.3% -7.29%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.89 0.92 0.98 1.00 0.83 0.82 0.83 0.86 0.79 0.78 0.66 0.81 0.811
Earnings Stability — — — — — — — — 0.91 0.61 0.78 0.92 0.71 0.43 0.81 0.22 0.71 0.62 0.63 0.57 0.567
Margin Stability — — — — — — — — 0.96 0.95 0.95 0.95 0.94 0.95 0.94 0.94 0.94 0.93 0.93 0.95 0.946
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.20 0.50 0.50 0.89 0.50 0.99 0.50 0.90 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — 0.00 — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.03 -0.03 -0.02 -0.04 -0.01 -0.00 -0.01 0.01 -0.00 -0.17 -0.20 -0.22 -0.219
Gross Margin Trend — — — — — — — — -0.04 -0.05 -0.05 -0.05 -0.05 -0.04 -0.03 -0.03 -0.03 -0.04 -0.04 -0.01 -0.015
FCF Margin Trend — — — — — — — — 0.02 0.04 0.05 0.12 0.22 0.18 0.14 0.06 -0.08 -0.10 -0.11 -0.11 -0.114
Sustainable Growth Rate 0.4% 0.1% — — — 0.6% — — — — — — — — — — — — — — —
Internal Growth Rate 0.3% 0.0% — — — 0.5% — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.82 28.86 -2.86 1.80 6.05 -4.75 3.57 0.22 -0.14 -0.43 -0.55 -0.88 -3.24 -4.22 -1.89 -2.37 0.15 0.07 0.10 0.07 0.075
FCF/OCF -0.13 0.61 0.34 2.09 1.35 1.80 2.21 8.36 -4.03 0.09 0.23 0.69 0.87 0.86 0.82 0.73 3.08 1.87 1.74 2.00 2.000
FCF/Net Income snapshot only 0.150
CapEx/Revenue 3.8% 3.6% 3.1% 3.2% 2.9% 6.0% 5.8% 5.5% 5.4% 2.5% 2.5% 2.4% 2.1% 1.8% 1.9% 2.1% 2.0% 2.0% 2.6% 2.9% 2.92%
CapEx/Depreciation snapshot only 0.508
Accruals Ratio 0.00 -0.01 -0.01 0.00 0.02 0.03 0.01 -0.01 -0.03 -0.03 -0.04 -0.07 -0.09 -0.06 -0.07 -0.04 -0.02 -0.13 -0.14 -0.16 -0.159
Sloan Accruals snapshot only -0.059
Cash Flow Adequacy snapshot only -1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% — — — 0.0% — — — — — — — — — — — — — — —
FCF Payout Ratio — 0.0% 0.0% — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — —
Total Payout Ratio 0.0% 0.0% — — — 2.8% — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.1% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.9% 5.0% 2.3% 0.8% 0.0% 0.01%
Net Buyback Yield -8.9% -11.7% -15.0% -15.1% -0.0% -0.1% -0.1% -0.1% 1.0% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.7% 4.8% 2.1% 0.6% -0.1% -0.10%
Total Shareholder Return -8.9% -11.7% -15.0% -15.1% -0.0% -0.1% -0.1% -0.1% 1.0% 3.6% 4.9% 6.3% 6.7% 2.6% 6.3% 7.7% 4.8% 2.1% 0.6% -0.1% -0.10%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.68 0.09 2.29 1.09 0.89 2.04 0.49 0.62 0.90 0.77 0.73 1.08 0.85 1.06 1.41 0.85 0.83 2.23 2.06 1.97 1.974
Interest Burden (EBT/EBIT) 0.82 0.73 -1.06 145.67 75.31 0.33 2.46 1.33 1.18 1.15 1.13 1.11 1.10 0.28 0.35 0.34 0.52 1.07 1.06 1.05 1.045
EBIT Margin 0.07 0.05 0.01 -0.00 -0.00 0.02 -0.01 -0.04 -0.07 -0.07 -0.07 -0.07 -0.05 -0.10 -0.12 -0.11 -0.15 -0.14 -0.17 -0.19 -0.189
Asset Turnover 0.08 0.16 0.22 0.30 0.32 0.33 0.33 0.35 0.36 0.38 0.39 0.39 0.40 0.40 0.40 0.40 0.40 0.42 0.44 0.44 0.440
Equity Multiplier 1.13 1.14 1.19 1.20 1.16 1.18 1.22 1.22 1.22 1.24 1.25 1.24 1.26 1.26 1.26 1.27 1.29 1.30 1.32 1.34 1.344
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.01 $0.00 $-0.01 $-0.02 $-0.02 $0.02 $-0.02 $-0.04 $-0.10 $-0.09 $-0.09 $-0.13 $-0.08 $-0.05 $-0.09 $-0.05 $-0.10 $-0.52 $-0.57 $-0.62 $-0.62
Book Value/Share $3.55 $3.56 $3.04 $3.06 $3.00 $3.10 $3.13 $3.12 $3.05 $3.01 $3.00 $2.96 $2.90 $3.06 $2.96 $2.97 $2.97 $2.67 $2.55 $2.49 $2.49
Tangible Book/Share $3.54 $3.43 $2.93 $2.95 $2.90 $3.00 $2.80 $2.81 $2.75 $2.71 $2.71 $2.67 $2.63 $2.78 $2.68 $2.70 $2.70 $2.40 $2.29 $2.24 $2.24
Revenue/Share $0.30 $0.64 $0.81 $1.10 $1.11 $1.20 $1.23 $1.29 $1.34 $1.48 $1.53 $1.50 $1.52 $1.55 $1.54 $1.54 $1.54 $1.57 $1.59 $1.60 $1.60
FCF/Share $-0.00 $0.04 $0.01 $-0.07 $-0.13 $-0.16 $-0.13 $-0.08 $-0.06 $0.00 $0.01 $0.08 $0.22 $0.17 $0.14 $0.09 $-0.05 $-0.07 $-0.10 $-0.09 $-0.09
OCF/Share $0.01 $0.06 $0.04 $-0.03 $-0.09 $-0.09 $-0.06 $-0.01 $0.01 $0.04 $0.05 $0.12 $0.25 $0.20 $0.17 $0.12 $-0.02 $-0.04 $-0.06 $-0.05 $-0.05
Cash/Share $3.32 $3.21 $2.71 $2.60 $2.46 $2.49 $2.21 $2.20 $2.12 $2.01 $2.06 $2.11 $2.09 $2.15 $2.07 $2.06 $2.05 $2.04 $2.04 $2.02 $2.02
EBITDA/Share $0.02 $0.04 $0.02 $0.02 $0.03 $0.06 $0.02 $-0.01 $-0.05 $-0.05 $-0.04 $-0.04 $-0.00 $-0.08 $-0.09 $-0.09 $-0.14 $-0.12 $-0.17 $-0.21 $-0.21
Debt/Share $0.00 $0.00 $0.11 $0.11 $0.11 $0.13 $0.13 $0.12 $0.11 $0.11 $0.11 $0.10 $0.07 $0.13 $0.12 $0.19 $0.28 $0.26 $0.28 $0.20 $0.20
Net Debt/Share $-3.32 $-3.21 $-2.60 $-2.49 $-2.35 $-2.36 $-2.08 $-2.08 $-2.00 $-1.90 $-1.95 $-2.00 $-2.02 $-2.02 $-1.95 $-1.88 $-1.78 $-1.78 $-1.76 $-1.82 $-1.82
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.300
Altman Z-Prime snapshot only 7.572
Piotroski F-Score 3 4 3 1 2 4 1 2 5 5 5 5 6 6 4 4 2 3 2 3 3
Beneish M-Score — — — — -1.28 -1.62 -1.54 -1.61 -1.79 -2.09 -2.42 -2.91 -2.92 -2.70 -2.69 -2.41 -2.39 -3.13 -3.37 -3.64 -3.638
Ohlson O-Score snapshot only -7.418
ROIC (Greenblatt) snapshot only -12.00%
Net-Net WC snapshot only $1.95
EVA snapshot only $-43913710.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 84.15 82.00 66.64 56.32 56.85 68.58 54.84 64.34 66.21 68.44 69.30 71.95 71.99 71.83 68.51 67.09 57.95 61.35 58.18 57.55 57.552
Credit Grade snapshot only 9
Credit Trend snapshot only -9.535
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 52
Sector Credit Rank snapshot only 50

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms